Navigare Ventures
VC Fund
Stockholm, Sweden
Navigare Ventures is an early-stage investor specialized in science-driven companies.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 48%
Last updated:
For AI agents: llms.txt
Industries Navigare Ventures invests in
Stages Navigare Ventures invests in
Countries Navigare Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $470k–$6M
- Series A
- $7.3M–$21M
- Venture - Series Unknown
- $858k–$8.5M
Investment Focus
Industry
- Biotechnology 6 (19%)
- Manufacturing 4 (13%)
- Energy 3 (10%)
- Information Technology 3 (10%)
- Electronics 2 (6%)
Stage
- Seed 12 (39%)
- Venture - Series Unknown 4 (13%)
- Series A 3 (10%)
- Series B 3 (10%)
- Pre-Seed 2 (6%)
Country
- Sweden 17 (55%)
- Denmark 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Elin Almstedt
Principal, Life Science
|
Principal, Life Science | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| We develop hardware solutions that offer best-in-class performance, size and weight by combining scalable manufacturing and cutting-edge design techniques.Our groundbreaking system-in-package (SiP) technology merges ultra-low loss, pinpoint precision, and featherlight design into one powerhouse solution.This innovation enables us to engineer RFsystems that deliver an unmatched combination of compactness, lightness, and high performance – redefining the future of wireless technology and outperforming conventional SoCs. | $12.6M / Seed / Sep 22, 2026 | ||
| EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide. | $7.6M / Venture - Series Unknown / Sep 22, 2026 | ||
| Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies. | $4.7M / Seed / Aug 20, 2026 | ||
| Pixelgen Technologies develops technologies for biomedical research and diagnostics. Pixelgen Technologies was founded in 2020 and was headquartered in Sweden. | $15.5M / Series B / Aug 20, 2026 | ||
| Arkeon Technologies is a deep-tech company developing innovative solutions for scalable superconducting quantum computing. Its patented technology enables precise post-fabrication tuning of qubit frequencies, improving quantum chip performance, yield, and reliability. By addressing key manufacturing challenges, Arkeon helps accelerate thedevelopment of large-scale quantum processors for next-generation computing. | $688.1K / Seed / Jun 11, 2026 | ||
| The objective of ProteomEdge is to use mass spectrometry to provide an analytical platform with cutting-edge precision for absolute protein quantification. | $857.9K / Venture - Series Unknown / Mar 25, 2026 | ||
| AlixLabs offers nanostructure fabrication methods using the atomic layer etching process. This method of nanostructure fabrication uses the atomic layer etching process, which is a damage-free etch process. AlixLabs offers an ALE-based method for producing nanostructures with characteristic sizes less than 20 nm. AlixLabs' technologyfabricates nanostructures beyond the resolution limit of optical and electron beam lithography, with applications in nanoelectronic device fabrication, for example. This invention, among other things, may enable an economically viable method of transistor channel scaling for sub-20 nm technology nodes. | $17.3M / Series A / Nov 20, 2025 | ||
| Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment. | $8.5M / Venture - Series Unknown / Oct 17, 2025 | ||
| Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers. | $2.2M / Seed / Jun 30, 2025 | ||
| IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform. | $3M / Seed / Mar 21, 2025 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Navigare Ventures invest in?
Navigare Ventures invests primarily in Biotechnology, Manufacturing and Energy startups, most often at Seed and Venture - Series Unknown stage. Most of the 31 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Navigare Ventures's check size?
Navigare Ventures typically joins rounds of $470k–$6M at Seed, $7.3M–$21M at Series A and $858k–$8.5M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Navigare Ventures participates in.
How do I contact Navigare Ventures?
Public channels for Navigare Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Navigare Ventures?
The team at Navigare Ventures includes Elin Almstedt (Principal, Life Science). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
